LIANY
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Aug 27 closing price
Capitalization
6.19M
75 days until earnings call
TRML
Price
$23.00
Change
-$0.51 (-2.17%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
591.69M
Interact to see
Advertisement

LIANY vs TRML

Header iconLIANY vs TRML Comparison
Open Charts LIANY vs TRMLBanner chart's image
LianBio
Price$0.06
Change+$0.01 (+20.00%)
Volume$9.1K
Capitalization6.19M
Tourmaline Bio
Price$23.00
Change-$0.51 (-2.17%)
Volume$3.46K
Capitalization591.69M
LIANY vs TRML Comparison Chart in %
Loading...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIANY vs. TRML commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a StrongBuy and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (LIANY: $0.06 vs. TRML: $23.51)
Brand notoriety: LIANY and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 2% vs. TRML: 88%
Market capitalization -- LIANY: $6.19M vs. TRML: $591.69M
LIANY [@Biotechnology] is valued at $6.19M. TRML’s [@Biotechnology] market capitalization is $591.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than LIANY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIANY’s TA Score shows that 5 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • LIANY’s TA Score: 5 bullish, 3 bearish.
  • TRML’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LIANY is a better buy in the short-term than TRML.

Price Growth

LIANY (@Biotechnology) experienced а +1.25% price change this week, while TRML (@Biotechnology) price change was +4.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

LIANY is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($592M) has a higher market cap than LIANY($6.19M). TRML YTD gains are higher at: 15.952 vs. LIANY (-78.604). TRML (-102.41M) and LIANY (-105.26M) have comparable annual earnings (EBITDA) . TRML has less debt than LIANY: TRML (145K) vs LIANY (2.84M). LIANY (0) and TRML (0) have equivalent revenues.
LIANYTRMLLIANY / TRML
Capitalization6.19M592M1%
EBITDA-105.26M-102.41M103%
Gain YTD-78.60415.952-493%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A239M-
Total Debt2.84M145K1,961%
TECHNICAL ANALYSIS
Technical Analysis
LIANYTRML
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
81%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAINX21.51N/A
N/A
Dunham International Stock A
MSDOX14.13N/A
N/A
Morgan Stanley Emerging Mkt ex China C
MSGNX6.68N/A
N/A
MassMutual Small Cap Gr Eq R3
FZABX30.26N/A
N/A
Fidelity Advisor Diversified Intl Z
DFEMX33.90-0.23
-0.67%
DFA Emerging Markets I

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+11.18%
SER - LIANY
69%
Closely correlated
-9.11%
GERN - LIANY
53%
Loosely correlated
-3.42%
TRML - LIANY
28%
Poorly correlated
+0.04%
OTLK - LIANY
23%
Poorly correlated
-12.04%
MTNB - LIANY
21%
Poorly correlated
-5.71%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+0.04%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
44%
Loosely correlated
-2.07%
STOK - TRML
43%
Loosely correlated
-0.36%
CRNX - TRML
42%
Loosely correlated
-1.71%
SYRE - TRML
42%
Loosely correlated
+0.47%
More